Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
51
HALO Quote, Financials, Valuation and Earnings
Last price:
$46.72
Seasonality move
:
7.09%
Day range:
$46.88 - $48.21
52-week range:
$33.15 - $65.53
Dividend yield:
0%
P/E ratio:
15.54x
P/S ratio:
6.43x
P/B ratio:
13.19x
Volume:
4.5M
Avg. volume:
2M
1-year change:
29%
Market cap:
$6B
Revenue:
$829.3M
EPS (TTM):
$3.02
HALO Analysts' Consensus Rating
The 7 analysts providing 12-month price projections for Halozyme Therapeutics shares anticipate an average target of $64.13, ranging from a low estimate of $52.00 to a high estimate of $75.00. This average target implies a growth of 36.64% compared to the current stock price of $46.93.
Consensus Price Target
$64.13
Highest Price Target
$75.00
Lowest Price Target
$52.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 4 | 3 | 3 |
| Hold | 3 | 5 | 4 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Hold | Hold |
HALO Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 3.8% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.65% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.96% over the past day.
